Mr Chen has replaced Elaine Zhao, who resigned effective at the close of business on June 30, 2010.
Most recently, Mr Chen was an independent advisor engaged in local RMB PE fundraising and providing M&A and PE advisory and due diligence services.
Prior to that, Mr Chen was a partner of Trenwith Securities, where he was engaged in and executed cross-border equity financing for various Chinese companies. He was also a senior business advisor of Ernst & Young and a senior financial advisor of IBM Global Services.
Ronghua Wang, chairman and CEO of Biostar Pharma, said: “Mr Chen’s strong financial background and extensive investment experience, in addition to his bilingual skills and bicultural background, will strengthen our capabilities in the execution of our growth strategy, financial management and corporate communications. We are confident that the new appointment will help create a stronger organisation and facilitate our future growth.”